AUM Biosciences, a Global Biotechnology Company Developing Precision Oncology Therapeutics, Announces Plans to Become a Public Company via Merger with Mountain Crest Acquisition Corp. V
Anand M -The transaction reflects a pre-money equity value of $400 million for AUM Biosciences -Transaction is expected to provide…